| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/29/2013 | CN101429185B Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/29/2013 | CN101322734B Codonopsis lanceolata total saponins with anti-inflammatory immunity function and preparation thereof |
| 05/28/2013 | CA2731995C Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 05/28/2013 | CA2727715C Vaccine composition |
| 05/28/2013 | CA2720946C Compounds and compositions as protein kinase inhibitors |
| 05/28/2013 | CA2710040C A soluble tumor necrosis factor receptor mutant |
| 05/28/2013 | CA2685447C Pharmaceutical composition |
| 05/28/2013 | CA2570786C Modified cpg-containing oligonucleotide multimers in immune stimulation |
| 05/28/2013 | CA2563260C Methods of treating autoimmune and inflammatory diseases |
| 05/28/2013 | CA2550625C Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 05/28/2013 | CA2544107C Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 05/28/2013 | CA2476935C Drug delivery system for subconjunctival administration of fine particles |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2473970C Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 05/28/2013 | CA2443372C Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides |
| 05/28/2013 | CA2440831C Combination therapy using cd40 and cd20 ligands |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2323210C Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
| 05/23/2013 | WO2013074055A1 Method for restoring and rejuvenating the human body and a pharmaceutical composition for implementation thereof |
| 05/23/2013 | WO2013072896A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain |
| 05/23/2013 | WO2013072415A1 Binding molecules for bcma and cd3 |
| 05/23/2013 | WO2013072406A1 Binding molecules for bcma and cd3 |
| 05/23/2013 | WO2013071880A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists |
| 05/23/2013 | WO2013071409A1 Clostridium difficile lipoteichoic acid and uses thereof |
| 05/23/2013 | WO2013071355A1 Soluble mediator |
| 05/23/2013 | WO2013048214A3 Novel heterocyclic derivatives and their uses |
| 05/23/2013 | WO2008147883A8 Prevention and treatment of complement-associated eye conditions |
| 05/23/2013 | US20130133092 Sequence-specific dna recombination in eukaryotic cells |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130131125 Therapeutic combination |
| 05/23/2013 | US20130131038 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/23/2013 | US20130131026 Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129680 Method for treating hepatitis c virus infection using quercetin-containing compositions |
| 05/23/2013 | US20130129678 Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer |
| 05/23/2013 | CA2856100A1 Nitrogen-containing fused ring compounds as crth2 antagonists |
| 05/23/2013 | CA2856085A1 Clostridium difficile lipoteichoic acid and uses thereof |
| 05/23/2013 | CA2852133A1 Soluble mediator |
| 05/23/2013 | CA2850591A1 Binding molecules for bcma and cd3 |
| 05/23/2013 | CA2849196A1 Binding molecules for bcma and cd3 |
| 05/22/2013 | EP2594586A1 IL-31 monoclonal antibodies and methods of use |
| 05/22/2013 | EP2594561A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain |
| 05/22/2013 | EP2594280A1 Activin neutralisers and uses thereof for treatment of diseases associated with aberrant "host defence response" activation |
| 05/22/2013 | EP2593548A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 05/22/2013 | EP2593467A1 Carbohydrate hapten-based anti-cancer vaccines and antibody drugs |
| 05/22/2013 | EP2593462A1 NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 05/22/2013 | EP2593115A1 Treatment of t-cell mediated immune disorders |
| 05/22/2013 | EP2593114A1 Method of treating graft versus host disease |
| 05/22/2013 | CN103119168A Human papillomavirus E7 antigen compositions and uses thereof |
| 05/22/2013 | CN103119054A VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof |
| 05/22/2013 | CN103119039A Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 05/22/2013 | CN103119038A 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists |
| 05/22/2013 | CN103119030A Matrix metalloproteinase inhibitors |
| 05/22/2013 | CN103119028A 1,2,4-Triazolone Derivative |
| 05/22/2013 | CN103119024A Isoquinoline derivative |
| 05/22/2013 | CN103119021A Anti-inflammatory agents |
| 05/22/2013 | CN103118694A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases |
| 05/22/2013 | CN103118691A Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with NOD2 agonist or cultured product thereof |
| 05/22/2013 | CN103113483A Method for extracting various active ingredients from dendrobium officinale |
| 05/22/2013 | CN103113466A Recombinant human interferon beta-1b modified by polyethylene glycol and preparation method of recombinant human interferon beta-1b |
| 05/22/2013 | CN103113382A Group of sesquiterpenoid coumarin and sesquiterpenoid chromone compounds |
| 05/22/2013 | CN103113375A Pyrazolo [3, 4-d] pyrimidine compounds and preparation method thereof |
| 05/22/2013 | CN103113307A 苯并咪唑类化合物及其应用 Benzimidazole compounds and their Applications |
| 05/22/2013 | CN103113303A Nitrogen heterocyclic compound used as CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells) receptor antagonist |
| 05/22/2013 | CN103110959A Application of diacylglycerol kinase alpha gene-chitosan nanoparticle in preparing medicine for treating allergic asthma |
| 05/22/2013 | CN103110944A Methods of administering anti-TNF alpha antibodies |
| 05/22/2013 | CN103110943A Novel vaccine adjuvant capable of replacing aluminum hydroxide |
| 05/22/2013 | CN103110928A Preparation method of traditional Chinese medicine prescription oral liquid for inhibiting human immunodeficiency virus (HIV) |
| 05/22/2013 | CN103110889A Traditional Chinese medicine for increasing immunity and preparation method thereof |
| 05/22/2013 | CN103110883A Traditional Chinese medicine composition for treating inflammation |
| 05/22/2013 | CN103110689A Novel method for extracting astragaloside from radix astragali |
| 05/22/2013 | CN103110688A Soft capsule capable of enhancing immune function and preparation method thereof |
| 05/22/2013 | CN103110676A Method and device for dynamically continuously and circularly extracting total ginsenoside contained in ginseng medicinal material |
| 05/22/2013 | CN103110669A Preparation method of sanlingling (Chinese character) oral liquid |
| 05/22/2013 | CN103110621A Applications of tea double-chlorine carboxamide and tea double-bromine carboxamide or like in preparation of products for prevention and treatment of diseases such as cancer |
| 05/22/2013 | CN103110615A Preparation method of microelement zinc-iron raw injection for pig |
| 05/22/2013 | CN103110604A Soft polyprenol capsule and its making method |
| 05/22/2013 | CN103110576A Lentinan injection preparation and preparation method thereof |
| 05/22/2013 | CN103110573A Chlorpheniramine maleate cream or gel and preparation method thereof |
| 05/22/2013 | CN103110539A Sensitive skin cream |
| 05/22/2013 | CN103110109A Radix isatidis VC tablet and preparation method |
| 05/22/2013 | CN102525980B Children cetirizine hydrochloride composition |
| 05/22/2013 | CN102512458B Semi-bionic extraction method for active components of cordyceps militaris |
| 05/22/2013 | CN102453661B Formula of health-care wine and making method thereof |
| 05/22/2013 | CN102399299B Preparation method for tuckahoe acidic polysaccharide extract and application of tuckahoe acidic polysaccharide extract |
| 05/22/2013 | CN102343034B Composition applied to side effects caused by tumor radiation and pharyngitis as well as preparing method thereof |
| 05/22/2013 | CN102232961B Pharmaceutical composition for preventing and treating respiratory anaphylactic disease |
| 05/22/2013 | CN102106827B Lentinan granule as well as preparation method and use of lentinan granule |
| 05/22/2013 | CN102018982B Humidifier health-care tablet and preparation method thereof |
| 05/22/2013 | CN101897752B Chinese medicinal composition and preparation method thereof |
| 05/22/2013 | CN101897662B Ophtalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/22/2013 | CN101863942B Method for preparing isoprinosine and oral preparation thereof |
| 05/22/2013 | CN101862331B New use of methyl liensinine |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/22/2013 | CN101848725B 组合物 The composition |
| 05/22/2013 | CN101668534B IgA产生促进剂 IgA production promoting agent |
| 05/22/2013 | CN101124014B Mucosal immunogenic substances comprising a polyinosinic acid - polycytidylic acid based adjuvant |